ANTH — Anthera Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Anthera Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2013 December 31st	2014 December 31st	2015 December 31st	2016 December 31st	2017 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25.9	2.64	47	20.8	2.2
Net Total Accounts Receivable
Net Total Receivables	—	—	0.326	0	—
Prepaid Expenses
Total Current Assets	26.3	3.02	47.9	22.7	3.19
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.812	0.468	0.263	0.763	0.482
Other Long Term Assets
Total Assets	37.4	3.49	48.1	23.5	3.67
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.56	5.75	8.47	10.6	4.71
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.7	5.75	8.47	11	9.17
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14.8	-2.26	39.7	12.5	-5.5
Total Liabilities & Shareholders' Equity	37.4	3.49	48.1	23.5	3.67
Total Common Shares Outstanding
Total Preferred Shares Outstanding